We use cookies to understand how you use our site and to improve your experience.
This includes personalizing content and advertising.
By pressing "Accept All" or closing out of this banner, you consent to the use of all cookies and similar technologies and the sharing of information they collect with third parties.
You can reject marketing cookies by pressing "Deny Optional," but we still use essential, performance, and functional cookies.
In addition, whether you "Accept All," Deny Optional," click the X or otherwise continue to use the site, you accept our Privacy Policy and Terms of Service, revised from time to time.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Countdown to DexCom (DXCM) Q4 Earnings: Wall Street Forecasts for Key Metrics
Read MoreHide Full Article
Wall Street analysts forecast that DexCom (DXCM - Free Report) will report quarterly earnings of $0.65 per share in its upcoming release, pointing to a year-over-year increase of 44.4%. It is anticipated that revenues will amount to $1.25 billion, exhibiting an increase of 12.4% compared to the year-ago quarter.
The consensus EPS estimate for the quarter has been revised 0.2% higher over the last 30 days to the current level. This reflects how the analysts covering the stock have collectively reevaluated their initial estimates during this timeframe.
Before a company announces its earnings, it is essential to take into account any changes made to earnings estimates. This is a valuable factor in predicting the potential reactions of investors toward the stock. Empirical research has consistently shown a strong correlation between trends in earnings estimate revisions and the short-term price performance of a stock.
While it's common for investors to rely on consensus earnings and revenue estimates for assessing how the business may have performed during the quarter, exploring analysts' forecasts for key metrics can yield valuable insights.
In light of this perspective, let's dive into the average estimates of certain DexCom metrics that are commonly tracked and forecasted by Wall Street analysts.
It is projected by analysts that the 'Revenue- Hardware' will reach $38.01 million. The estimate indicates a change of -15.5% from the prior-year quarter.
The collective assessment of analysts points to an estimated 'Revenue- Sensor and other' of $1.20 billion. The estimate indicates a change of +12% from the prior-year quarter.
Analysts expect 'Revenue- United States' to come in at $886.13 million. The estimate indicates a change of +10.4% from the prior-year quarter.
The average prediction of analysts places 'Revenue- International' at $356.26 million. The estimate points to a change of +14.7% from the year-ago quarter.
DexCom shares have witnessed a change of -1.2% in the past month, in contrast to the Zacks S&P 500 composite's no move. With a Zacks Rank #3 (Hold), DXCM is expected closely follow the overall market performance in the near term. You can see the complete list of today's Zacks Rank #1 (Strong Buy) stocks here >>>> .
View the Zacks #1 Rank List
Image: Bigstock
Countdown to DexCom (DXCM) Q4 Earnings: Wall Street Forecasts for Key Metrics
Wall Street analysts forecast that DexCom (DXCM - Free Report) will report quarterly earnings of $0.65 per share in its upcoming release, pointing to a year-over-year increase of 44.4%. It is anticipated that revenues will amount to $1.25 billion, exhibiting an increase of 12.4% compared to the year-ago quarter.
The consensus EPS estimate for the quarter has been revised 0.2% higher over the last 30 days to the current level. This reflects how the analysts covering the stock have collectively reevaluated their initial estimates during this timeframe.
Before a company announces its earnings, it is essential to take into account any changes made to earnings estimates. This is a valuable factor in predicting the potential reactions of investors toward the stock. Empirical research has consistently shown a strong correlation between trends in earnings estimate revisions and the short-term price performance of a stock.
While it's common for investors to rely on consensus earnings and revenue estimates for assessing how the business may have performed during the quarter, exploring analysts' forecasts for key metrics can yield valuable insights.
In light of this perspective, let's dive into the average estimates of certain DexCom metrics that are commonly tracked and forecasted by Wall Street analysts.
It is projected by analysts that the 'Revenue- Hardware' will reach $38.01 million. The estimate indicates a change of -15.5% from the prior-year quarter.
The collective assessment of analysts points to an estimated 'Revenue- Sensor and other' of $1.20 billion. The estimate indicates a change of +12% from the prior-year quarter.
Analysts expect 'Revenue- United States' to come in at $886.13 million. The estimate indicates a change of +10.4% from the prior-year quarter.
The average prediction of analysts places 'Revenue- International' at $356.26 million. The estimate points to a change of +14.7% from the year-ago quarter.
View all Key Company Metrics for DexCom here>>>DexCom shares have witnessed a change of -1.2% in the past month, in contrast to the Zacks S&P 500 composite's no move. With a Zacks Rank #3 (Hold), DXCM is expected closely follow the overall market performance in the near term. You can see the complete list of today's Zacks Rank #1 (Strong Buy) stocks here >>>> .